Literature DB >> 9737285

HIV-1-associated nephropathy and response to highly-active antiretroviral therapy.

R K Wali, C I Drachenberg, J C Papadimitriou, S Keay, E Ramos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737285     DOI: 10.1016/S0140-6736(98)24037-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.

Authors:  Mohamed G Atta; Derek M Fine; Gregory D Kirk; Shruti H Mehta; Richard D Moore; Gregory M Lucas
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

2.  Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy.

Authors:  E T Overton; D Nurutdinova; J Freeman; W Seyfried; K E Mondy
Journal:  HIV Med       Date:  2009-03-11       Impact factor: 3.180

Review 3.  Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.

Authors:  Marina Núñez; Anita M Saran; Barry I Freedman
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

4.  Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors.

Authors:  Warren A Andiman; Miriam C Chernoff; Charles Mitchell; Murli Purswani; James Oleske; Paige L Williams; Hans Spiegel; Phil Gona; George R Seage
Journal:  Pediatr Infect Dis J       Date:  2009-07       Impact factor: 2.129

Review 5.  Hypertension in the HIV-infected patient.

Authors:  S Aoun; E Ramos
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 6.  The treatment of HIV-associated nephropathy.

Authors:  Robert C Kalayjian
Journal:  Adv Chronic Kidney Dis       Date:  2010-01       Impact factor: 3.620

7.  Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis.

Authors:  Paul R Bohjanen; Melissa D Johnson; Lynda A Szczech; Dannah W Wray; William P Petros; Cameron R Miller; Charles B Hicks
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 8.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Renal Dysfunction in HIV-1-infected Patients.

Authors:  Jeffrey B. Kopp
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

10.  Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Authors:  Amanda Mocroft; Christina Wyatt; Lynda Szczech; Jacquie Neuhaus; Wafaa El-Sadr; Russell Tracy; Lewis Kuller; Michael Shlipak; Brian Angus; Harting Klinker; Michael Ross
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.